SR biotek is a cosmetics manufacturer founded in 2007 that specializes in functional cosmetics and is listed on the KONEX market. Its core technology is Altum peptide, a new material that combines microneedles with peptides, which was developed in 2020 and launched in 2021.
Since 2023 the company has reduced OEM/ODM contract production and pushed its own brand, E-Dinell, into the professional channel. Its earnings commentary links the margin improvement to the growth of own-brand sales.
Company profile information on a recruitment platform puts overseas sales at more than 95% of revenue, with partners spread across more than 100 countries including the United States, France, the United Kingdom, the Middle East and South America.
The company states that more than KRW 3 billion in research funding has been invested over 15 years in the Altum patent technology. It has registered patents and trademarks in Europe and the United States to broaden its overseas base. R&D spending in 2025 was KRW 1.09 billion, equal to 2.92% of revenue.
Within the cosmetics sector, share price performance diverges by company depending on overseas sales mix, product competitiveness and order and earnings outlooks.